The efficacy and safety of using the topical medicine with combined action in patients with opportunistic vaginal infections
- Authors: Prilepskaya V.N.1, Bairamova G.R.1, Mezhevitinova E.A.1, Donnikov A.E.1, Trofimov D.Y.1, Ivanets T.Y.1, Kukes I.V.2
-
Affiliations:
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- International Association of Clinical Pharmacologists and Pharmacists
- Issue: Vol 22, No 5 (2020)
- Pages: 22-26
- Section: ORIGINAL ARTICLE
- URL: https://ogarev-online.ru/2079-5831/article/view/44847
- DOI: https://doi.org/10.26442/20795696.2020.5.200397
- ID: 44847
Cite item
Full Text
Abstract
Relevance. Infections of the lower genital tract are one of the most common reasons for women to visit a gynecologist. According to various authors, among all vulvovaginitis, the highest percentage of patients visiting a doctor is bacterial vaginosis (20–50%), vulvovaginal candidiasis (17–39%), trichomoniasis (10%) and other genital infections (10%). In the management of patients with infectious processes of the genitals, the choice of the method of therapy is of great importance, which allows not only to influence the microbes-associates, detected in high concentrations in the woman’s vagina during the initial episode of the disease, but also to prevent the development of relapses.
Aim. To evaluate the clinical and laboratory efficacy, adherence and long-term results of benzydamine use in patients with vulvovaginal candidiasis, aerobic vaginitis and bacterial vaginosis
Materials and methods. The study included 31 women aged 18 to 49 years, who complained of abundant discharge from the genital tract, itching, burning, dyspareunia. A comprehensive clinical and laboratory examination was carried out, including the collection of anamnestic data, general and special gynecological examination, microscopy of vaginal smears, KOH test, determination of the pH of the vaginal environment, assessment of vaginal microbiocenosis by quantitative PCR in real time. All patients were prescribed benzydamine hydrochloride, which was used as monotherapy in the form of a vaginal solution according to the recommended treatment regimen specified in the instructions for medical use of the drug Tantum® Rosa 1 (irrigation 2 times a day for 10 days).
Results. In 12–19 days after beginning treatment, 25 (80.6%) of 31 patients with laboratory signs of vaginal microflora alterations showed restoration of the normal vaginal biocenosis laboratory parameters. Of them, 8 patients initially had dysbiosis, 12 patients – yeast-like fungi, 4 patients – aerobic vaginitis and 1 patient – a combination of dysbiosis and fungi. Herewith, all patients also noted clinical signs of improvement. In 12–19 days after beginning treatment, 6 (1.4%) of 31 patients with laboratory signs of vaginal biocenosis alterations had unsatisfactory laboratory parameters; that is vaginal biocenosis alterations (a decrease in Lactobacillus spp. percentage). At the same time, there were no clinical signs of pronounced inflammation such as pathological discharge, hyperemia, vaginal swelling.
Conclusion. Benzydamine hydrochloride can be widely used in gynecological practice due to its combined effects on inflammation of the vagina, good clinical and microbiological results. It is important to note that additional therapy with drugs which contain lactobacilli is required only in 19.4% of cases. The clinical and laboratory effectiveness of benzydamine hydrochloride (Tantum® Rosa) was 96.8%, since the relapse rate after 30–60 days of the study did not exceed 3.2%.
Full Text
##article.viewOnOriginalSite##About the authors
Vera N. Prilepskaya
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Author for correspondence.
Email: v_prilepskaya@oparina4.ru
ORCID iD: 0000-0002-7643-8346
D. Sci. (Med.), Prof., Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowGiuldana R. Bairamova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: v_prilepskaya@oparina4.ru
D. Sci. (Med.), Prof., Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowElena A. Mezhevitinova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: v_prilepskaya@oparina4.ru
D. Sci. (Med.), Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowAndrei E. Donnikov
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: v_prilepskaya@oparina4.ru
Cand. Sci. (Med.), Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowDmitry Yu. Trofimov
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: v_prilepskaya@oparina4.ru
D. Sci. (Biol.), Prof. RAS, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowTatyana Yu. Ivanets
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: v_prilepskaya@oparina4.ru
D. Sci. (Med.), Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, MoscowIlia V. Kukes
International Association of Clinical Pharmacologists and Pharmacists
Email: v_prilepskaya@oparina4.ru
Cand. Sci. (Med.), International Association of Clinical Pharmacologists and Pharmacists
Russian Federation, MoscowReferences
- Vaginitis: Diagnosis and Treatment HEATHER L. PALADINE, MD, MEd, and URMI A. DESAI, MD, MS. Am Fam Physician. 2018; 97 (5): 321–9.
- Abdul-Aziz M, Mahdy MAK, Abdul-Ghani R et al. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana’a city, Yemen. BMC Infect Dis 2019; 19 (1): 879.
- Jahic M, Mulavdic M, Nurkic J et al. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis. Med Arch 2013; 67 (6): 428–30.
- Fan A, Yue Y, Geng N et al. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet 2013; 287 (2): 329–35.
- Прилепская В.Н., Кира Е.Ф., Гомберг М.А. и др. Федеральные клинические рекомендации. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М., 2019. [Prilepskaya V.N., Kira E.F., Gomberg M.A. et al. Federal clinical guidelines. Diagnostics and treatment of diseases accompanied by pathological discharge from the genital tract of women. Moscow, 2019 (in Russian).]
- Дикке Г.Б. Полимикробные ассоциации в этиологии воспалительных заболеваний половых органов у женщин. Акушерство и гинекология. 2017; 6: 151–8. [Dikke G.B. Polimikrobnye assotsiatsii v etiologii vospalitel’nykh zabolevanii polovykh organov u zhenshchin. Akusherstvo i ginekologiia. 2017; 6: 151–8 (in Russian).]
- Verboon-Maciolek MA, Gerards LJ, Stoutenbeek P, van Loon AM. Congenital infection: diagnostic serology of the mother not always definitive. Ned Tijdschr Geneeskd 2001; 145 (4): 153–6.
- Coudray MS, Madhivanan P. Bacterial Vaginosis – A Brief Synopsis of the Literature. European J Obstet Gynecol Reprod Biol 2019; 245.
- Bradshaw CS, Sobel JD. Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation. J Infect Dis 2016; 214 (Suppl. 1): S14–20.
- Kalia N, Singh J, Kaur M. Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions. Front Immunol 2019; 10: 2034. doi: 10.3389/fimmu.2019.02034
- Менухова Ю.Н. Бактериальный вагиноз: этиопатогенез, клинико-лабораторные особенности. Журн. акушерства и женских болезней. 2013; 4: 79–87. [Menukhova Iu.N. Bakterial’nyi vaginoz: etiopatogenez, kliniko-laboratornye osobennosti. Zhurn. akusherstva i zhenskikh boleznei. 2013; 4: 79–87 (in Russian).]
- Centers for Disease Control and Prevention. STD Treatment Guidelines. 2015.
- Ворошилина Е.С., Тумбинская Л.В., Донников А.Е. и др. Биоценоз влагалища с точки зрения количественной ПЦР: что есть норма? Акушерство и гинекология. 2011; 1: 57–65. [Voroshilina E.S., Tumbinskaia L.V., Donnikov A.E. et al. Biotsenoz vlagalishcha s tochki zreniia kolichestvennoi PTsR: chto est’ norma? Akusherstvo i ginekologiia. 2011; 1: 57–65 (in Russian).]
- Ворошилина Е.С., Кротова А.А., Хаютин Л.В. Количественная оценка биоценоза влагалища у беременных женщин методом ПЦР в реальном времени. М., 2008. [Voroshilina E.S., Krotova A.A., Khayutin L.V. Quantification of vaginal biocenosis in pregnant women by real-time PCR. Moscow, 2008 (in Russian).]
